| Threatened preterm labor: the influence of time factors on the incidence of respiratory distress syndrome. | |
| | |
MedLine Citation:
|
PMID: 6877685 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The interval between the first symptoms of threatened preterm labor and delivery was studied and found to be correlated with the incidence of respiratory distress syndrome (RDS), independent of treatment with corticosteroids or betamimetics and the state of the membranes. The incidence and severity of RDS decreased when labor was postponed for a period ranging from 12 hours to three weeks after admission. The decrease was most marked in a steroid-treated group but also occurred in the placebo-treated and untreated groups. The combination of orciprenaline and betamethasone was more effective in postponing delivery in early pregnancies than was the combination of orciprenaline and placebo. Treatment with betamimetics and corticosteroids is therefore indicated in cases of active preterm labor. |
| | |
Authors:
|
M F Schutte; P E Treffers; J G Koppe |
Related Documents
:
|
19452325 - Audit and feedback: effects on professional obstetrical practice and healthcare outcome... 8051495 - Vaginal birth after cesarean section in a university setting. 16647685 - Premature rupture of the fetal membranes: is the amnion the major determinant? 11776675 - Fetal and maternal energy metabolism during labor in relation to the available caloric ... 17080915 - Outcome of pregnancies complicated by systemic sclerosis and mixed connective tissue di... 21549725 - Gentle vs. aversive handling of pregnant ewes: i. maternal cortisol and behavior. |
Publication Detail:
|
Type: Comparative Study; Journal Article |
Journal Detail:
|
Title: Obstetrics and gynecology Volume: 62 ISSN: 0029-7844 ISO Abbreviation: Obstet Gynecol Publication Date: 1983 Sep |
Date Detail:
|
Created Date: 1983-09-23 Completed Date: 1983-09-23 Revised Date: 2009-10-26 |
Medline Journal Info:
|
Nlm Unique ID: 0401101 Medline TA: Obstet Gynecol Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 287-93 Citation Subset: AIM; IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Betamethasone / therapeutic use Double-Blind Method Female Fetal Membranes, Premature Rupture / complications Fetal Organ Maturity Gestational Age Hospitalization Humans Infant, Newborn Lung / embryology Male Obstetric Labor, Premature / prevention & control* Orciprenaline / therapeutic use Pregnancy Random Allocation Respiratory Distress Syndrome, Newborn / etiology, prevention & control* Risk Time Factors |
| Chemical | |
Reg. No./Substance:
|
378-44-9/Betamethasone; 586-06-1/Orciprenaline |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Neonatal outcome among low birth weight infants delivered spontaneously or by low forceps.
Next Document: Benefits of a statewide high-risk perinatal program.